|
KMID : 0911820170180010001
|
|
Korean Journal of Headache
2017 Volume.18 No. 1 p.1 ~ p.4
|
|
|
Recommendations and Guidelines on the Treatment of Cluster Headache
|
|
Sohn Jong-Hee
Cho Soo-Jin
|
|
|
Abstract
|
|
|
|
Cluster headache is famous for severe unilateral pain, accompanying ipsilateral cranial autonomic symptoms, and men headache. Cluster headache is a rare, but very disabling primary headache disorder that is often not optimally treated. After the systematic review of American Academy of Neurology in 2010, American Headache Society recently updated and published the evidence-based guideline about treatment of cluster headache in 2016. According to the guideline, suboccipital steroid injections is the only preventive treatment to receive a Level A recommendation. Lithium, verapamil, warfarin, and melatonin have been given a Level C recommendation for preventive treatment (possibly effective). For acute treatment, sumatriptan subcutaneous, zolmitriptan nasal spray, and high-flow oxygen remain the treatment with a Level A recommendation and sumatriptan nasal spray, oral zolmitriptan, and sphenopalatine ganglion stimulation has been administrated a Level B recommendation. For more effective treatment option for cluster headache, prospective clinical or observation trials are strongly warranted.
|
|
|
KEYWORD
|
|
|
Cluster headache, Guideline, Steroid, Treatment, Verapamil, Zolmitriptan
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|